创伤性失血性休克最初数小时:晶体液扩容策略是否仍有意义
本文为综述,评估创伤性失血性休克最初数小时低容量液体复苏的现有证据,重点关注其与允许性低血压、血管升压药使用及创伤性脑损伤脑灌注压的整合。当前指南建议在出血控制前滴定液体并使用血管升压药以达到最低血压目标;合并严重出血的创伤性脑损伤时血压目标升高。支持这些推荐的科学证据有限,多个方面仍存争议,指南在液体种类、容量和给药方案上缺乏针对特定创伤场景和人群的强证据。晶体液复苏在早期创伤救治中仍有意义,但其应用须结合新证据和不断变化的实践重新评估,需进一步研究明确安全液体容量和血管升压药的作用。
要点
- 当前指南建议创伤性失血性休克在出血控制前滴定液体并使用血管升压药,以达到最低血压目标。
- 合并严重出血的创伤性脑损伤时,血压目标升高。
- 支持上述推荐的科学证据有限,液体种类、容量和给药方案缺乏针对特定创伤场景和人群的强证据。
- 晶体液复苏在早期创伤救治中仍有意义,但其应用须结合新证据和不断变化的实践重新评估。
- 需进一步研究明确安全液体容量和血管升压药的作用,并整合先进监测技术优化创伤救治。
适用人群与场景
- 创伤性失血性休克患者,处于最初数小时早期救治阶段。
- 合并严重出血的创伤性脑损伤患者(血压目标升高)。
处置流程与药物剂量
- 当前指南建议:在出血控制前滴定液体并使用血管升压药,以达到最低血压目标。
- 合并严重出血的创伤性脑损伤时,血压目标升高。
研究设计与关键结果
- 综述评估创伤性失血性休克最初数小时低容量液体复苏的现有证据,强调其与允许性低血压、血管升压药使用及创伤性脑损伤脑灌注压的整合。
- 当前指南推荐滴定液体和使用血管升压药以达到最低血压目标直至出血控制,但支持这些推荐的科学证据有限,多个方面仍存争议。
- 指南在液体种类、容量和给药方案上缺乏针对特定创伤场景和人群的强证据。
- 即时检验诊断、集成监测系统和机器学习等新兴技术可能增强创伤救治的临床决策,帮助回答关键未解问题并改善生存。
证据类型、等级与局限
- 证据类型:综述。
- 局限:支持当前推荐的文献有限;缺乏针对特定创伤场景和人群的液体种类、容量和给药方案的强证据;多个方面仍存科学争议。
对床旁实践的改变
- 当前指南建议在出血控制前滴定液体并使用血管升压药,以达到最低血压目标;合并严重出血的创伤性脑损伤时血压目标升高。
- 作者认为,晶体液复苏在早期创伤救治中仍有意义,但其应用须结合新证据和不断变化的实践重新评估。
- 作者认为,需进一步研究以完善液体复苏指南,特别是明确安全液体容量和血管升压药的作用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Crystalloid-based fluid resuscitation has long been a cornerstone in the initial management of trauma-induced hemorrhagic shock. However, its benefit is increasingly questioned as it is suspected to increase bleeding and worsen coagulopathy. The emergence of alternative strategies like permissive hypotension and vasopressor use lead to a shift in early trauma care practices. Critical appraisal of current evidence is necessary to guide clinicians and outline research perspectives.
MAIN TEXT: Current guidelines for managing trauma-induced hemorrhagic shock suggest titrating fluids and using vasopressors to achieve minimal blood pressure targets until hemorrhage is controlled. In case of traumatic brain injury with severe hemorrhage, blood pressure target increases. The scientific literature supporting these recommendations is limited, and several aspects remain the subject of ongoing scientific debate. The aim of this review is to evaluate the existing evidence on low-volume fluid resuscitation during the first hours of trauma management, with an emphasis on its integration with permissive hypotension, vasopressor use and cerebral perfusion pressure in traumatic brain injury. The review also highlights the limitations of current guidelines, particularly the lack of robust evidence supporting specific type of fluid, volumes and administration protocols tailored to specific trauma scenarios and populations. Emerging technologies such as point-of-care diagnostics, integrated monitoring systems, and machine learning hold promise for enhancing clinical decision-making in trauma care. These innovations could play a crucial role, ultimately helping clinicians address critical unanswered questions in trauma management and improve patient survival.
CONCLUSIONS: Crystalloid-based resuscitation remains relevant in early trauma care, but its application must be reassessed considering recent evidence and evolving practices. Further research is essential to refine fluid resuscitation guidelines, particularly in defining safe fluid volumes and the role of vasopressors. The integration of advanced monitoring technologies may offer new opportunities to optimize trauma care and improve outcomes.
参考来源
- Tubert P, Kalimouttou A, Bouzat P, et al. Are crystalloid-based fluid expansion strategies still relevant in the first hours of trauma induced hemorrhagic shock? Crit Care. 2024. PMID: 39695790. doi:10.1186/s13054-024-05185-7
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。